Sign up for The A.V. Club's free newsletter to have the best TV, film, and news stories sent straight to your inbox. If there’s one thing John Oliver does better ...
Recruitment firms publish a steady stream of advice for employers and jobseekers: hiring guides, salary explainers, interview tips and market updates. Those pages can attract useful search traffic, ...
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. Credit...Video by Harsha Vadlamani Supported by By Alex Travelli ...
Did you pay for a generic prescription drug between May 2009 and December 2019? If so, you may be eligible to receive money from settlements involving some generic drug manufacturers. The Pennsylvania ...
Wilderness Bound is out now in Minecraft Java Edition! Pack your supplies and set off on an expedition into the dappled forest where the trails end and adventure begins. Seek out abandoned camps, ...
If you take a patented, brand-name medication — a cancer biologic, an autoimmune drug, a specialty injection — the supply chain behind that drug is about to be permanently restructured, starting at 12 ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...
The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...
President Donald Trump announced Tuesday that imported generic drugs will remain tariff-free for the next two years before facing steep new import duties, saying the move is designed to encourage ...
President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.